• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD ACCESS SYSTEMS POWERPORT TITANIUM ISP 6CF INT WSP ATT SL; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD ACCESS SYSTEMS POWERPORT TITANIUM ISP 6CF INT WSP ATT SL; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 8706060
Device Problems Fracture (1260); Suction Problem (2170); Obstruction of Flow (2423)
Patient Problems Pain (1994); Swelling (2091)
Event Date 08/21/2020
Event Type  Injury  
Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer and the evaluation is still pending.The investigation of the reported event is currently underway.Expiry date (08/2020).
 
Event Description
It was reported that one year five months post port placement the patient allegedly had pain and swelling around the catheter insertion point during slow flushing of saline.It was further reported that port allegedly was unable to aspirate blood prior to flushing.Reportedly the radiologist identified the catheter allegedly split and the port was successfully removed.The patient status was normal.
 
Manufacturer Narrative
H10: manufacturing review:a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record review is not required.Investigation summary: one powerport titanium isp with a catheter in two segments were returned for evaluation.The investigation is confirmed for the reported fracture as a longitudinal split was noted approximately 6.7cm from the distal end of the cath-lock.The edges of the longitudinal split were jagged.However, the investigation is inconclusive for the reported suction issue as the exact circumstances at the time of the reported event are unknown.A definitive root cause could not be determined based upon available information.Labeling review:a review of product labeling documentation (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4(expiry date: 08/2020).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that one year five months post port placement the patient allegedly had pain and swelling around the catheter insertion point during slow flushing of saline.It was further reported that port allegedly was unable to aspirate blood prior to flushing.Reportedly the radiologist identified the catheter allegedly split and the port was successfully removed.The patient status was normal.
 
Event Description
It was reported that one year five months post port placement the patient allegedly had pain and swelling around the catheter insertion point during slow flushing of saline.It was further reported that port allegedly was unable to aspirate blood prior to flushing.Reportedly the radiologist identified the catheter allegedly split and the port was successfully removed.The patient status was normal.
 
Manufacturer Narrative
H10: manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record review is not required.Investigation summary: one powerport titanium isp with a catheter in two segments were returned for evaluation.The investigation is confirmed for the reported fracture as a longitudinal split was noted approximately 6.7cm from the distal end of the cath-lock.The edges of the longitudinal split were jagged.However, the investigation is inconclusive for the reported suction issue as the exact circumstances at the time of the reported event are unknown.A definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documentation (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4(expiry date: 08/2020),g4.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT TITANIUM ISP 6CF INT WSP ATT SL
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
BARD ACCESS SYSTEMS
605 n. 5600 w.
salt lake city UT 84116
MDR Report Key10559473
MDR Text Key207697434
Report Number3006260740-2020-03316
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741098871
UDI-Public(01)00801741098871
Combination Product (y/n)N
PMA/PMN Number
K072549
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 01/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number8706060
Device Lot NumberRECV2159
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/17/2020
Initial Date Manufacturer Received 08/25/2020
Initial Date FDA Received09/21/2020
Supplement Dates Manufacturer Received11/30/2020
01/21/2021
Supplement Dates FDA Received12/11/2020
01/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age54 YR
-
-